Chapter 6 : Succumbing to the Mysteries of Microbiology and Immunology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Succumbing to the Mysteries of Microbiology and Immunology, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818128/9781555811907_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555818128/9781555811907_Chap06-2.gif


Researchers determined which cytokines induced the two activated antimicrobial macrophage effector reactions-resistance to infection and intracellular killing-and which cytokines shut down the killing. The author made inroads in the understanding of infections, devised a polymerase chain reaction-based detection system and an attenuated and subunit vaccine, and explored the use of immunomodulation with bacille-Calmette-Guerin (BCG) with great success. In this chapter the author seeks additional philanthropic funds to assist companies and academic investigators in the clinical development of new anti-TB drugs. The path is set for the foundation, and there is great excitement both within the foundation and the research community. Sequella, Inc., is working with investigators in universities around the world and has licensed some innovative, useful products for diagnosis and treatment of tuberculosis (TB). It is currently raising money to fund the development of its products and hopes to have at least one of its new TB products in the marketplace by the year 2001.

Citation: Nacy C. 2000. Succumbing to the Mysteries of Microbiology and Immunology, p 43-50. In Atlas R (ed), Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch6
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Citation: Nacy C. 2000. Succumbing to the Mysteries of Microbiology and Immunology, p 43-50. In Atlas R (ed), Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch6
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Sim, B. K. L.,, M. O’Reilly,, H. Liang,, A. H. Fortier,, W. He,, J. W. Madsen,, R. Lapcevich,, and C. A. Nacy. 1997. Recombinant human Angiostatin TM protein: An antiangiogenic protein with inhibitory activity against experimental metastatic cancer. Cancer Res. 57: 1329 1334.
2. Dijkstra, J.,, G. M. Swartz,, J. J. Raney,, J. Aniagolu,, L. Toro,, C. A. Nacy,, and S. J. Green. 1996. Interaction of anti-cholesterol antibodies with human lipoproteins. J. Immunol. 157: 2006 2013.
3. Robledo, S.,, D. Leiby,, C. Nacy,, L. Toro,, L. Valderrama,, and N. Saravia. 1996. Cytokine induction, differentiation antigen, and adhesion molecule expression in human mononuclear phagocytes infected with Leishmania (viannia). FASEB J. 10: 1060 1067.
4. James, S. L.,, and C. Nacy. 1993. Effector functions of activated macrophages against parasites. Curr. Opin. Immunol. 5: 518 523.
5. Mock, B.,, J. Blackwell,, J. Hilgers,, M. Potter,, and C. Nacy. 1993. Genetic-control of Leishmania-major infection in congenic, recombinant inbred and F2 populations of mice. European J. Immunogen. 20: 335 348.
6. Leiby, D. A.,, R. D. Schreiber,, and C. A. Nacy. 1993. IFN-γ produced in vivo during the first two days is critical for resolution of murine Leishmania major infections. Microb. Path. 14: 495 500.
7. Fortier, A. H.,, T. Polsinelli,, S. J. Green,, and C. A. Nacy. 1992. Activation of macrophages to kill Francisella tularensis: Identification of effector cells, activation cytokines, and effector molecules. Infect. Immun. 60: 817 825.
8. Mellouk, S.,, S. J. Green,, C. A. Nacy,, and S. L. Hoffman. 1991. Destruction of Plasmodium berghei sporozoites by hepatocytes involves nitric oxides. J. Immunol. 146: 3971 3976.
9. Davis, C. E.,, M. Belosevic,, M. S. Meltzer,, and C. A. Nacy. 1988. Regulation of macrophage antimicrobial activities: Cooperation of lymphokines for induction of resistance to infection. J. Immunol. 141: 627 635.
10. Mock, B. A.,, A. H. Fortier,, M. Potter,, J. Blackwell,, and C. A. Nacy. 1985. Genetic control of systemic Leishmania major infection: Identification of subline differences for susceptibility to disease. Curr. Top. Microbiol. Immunol. 122: 115 121.
11. Haverly, A. L.,, M. G. Pappas,, R. R. Henry,, and C. A. Nacy. 1983. In vitro macrophage antimicrobial activities and in vivo susceptibility to Leishmania tropica infection. Adv. Exper. Med. Biol. 162: 433 439.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error